Printer Friendly

CELOX ANNOUNCES PUBLIC OFFERING

 CELOX ANNOUNCES PUBLIC OFFERING
 MINNEAPOLIS, Jan. 24 /PRNewswire/ -- Celox Corporation announced


today that it has filed a registration statement with the Securities and Exchange Commission for the sale of 1,495,000 shares of its common stock, $.01 par value. The shares will be sold to the public through Mathews, Holmquist & Associates, Inc. The company expects the offering to become available to the public in March, at a price of between $3.00 and $3.50 per share.
 Minneapolis-based Celox Corporation is a developing biotechnology company that researches, develops, manufactures and markets cell biology products. The company has 1,382,769 shares of common stock outstanding prior to the offering and will have 2,682,769 shares after the offering. Proceeds of the offering are to be used for working capital.
 A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This notice shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
 Copies of the preliminary prospectus are available through David Merrill of Mathews, Holmquist & Associates, 100 North Sixth Street, Suite 306C, Minneapolis, Minn. 55403.
 -0- 1/24/92
 /CONTACT: Milo R. Polovina of Celox, 612-933-2616, or David Merrill of Mathews, Holmquist & Associates, 612-337-5880, for Celox/ CO: Celox Corporation ST: Minnesota IN: SU: OFR


AL -- MN015 -- 3275 01/24/92 16:46 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 24, 1992
Words:288
Previous Article:FLORIDA REGIONAL STOCK REPORT FOR FRIDAY, JAN. 24
Next Article:PLCB TO TAKE MESSAGE TO PENNSYLVANIA AUTO SHOW
Topics:


Related Articles
CELOX CORPORATION ANNOUNCES PUBLIC OFFERING
CELOX SIGNS WESTERN STATES DISTRIBUTION PACT
CELOX GRANTS DISTRIBUTION RIGHTS IN JAPAN
CELOX DELIVERS FIRST SHIPMENT TO JAPAN
CELOX FILES WITH FDA FOR NEW REGISTRATION STATUS TO BECOME A MEDICAL DEVICE COMPANY -- WILL ALLOW COMPANY TO ENTER NEW BIOTECH MARKETS
CELOX BEGINS DISTRIBUTION AGREEMENT IN TAIWAN
CELOX ANNOUNCES ADDITION TO BOARD OF DIRECTORS
CELOX CORPORATION ANNOUNCES THIRD QUARTER RESULTS
CELOX CORPORATION ANNOUNCES COLLABORATION WITH MEMORIAL BLOOD CENTERS OF MINNESOTA
Celox Laboratories, Inc. Announces Delisting Notice from Nasdaq

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters